Please login to the form below

Not currently logged in
Email:
Password:

EFPIA director general Richard Bergström resigns

Will remain in the role until a successor has been selected

EFPIA Richard BergstromRichard Bergström, director general of The European Federation of the Pharmaceutical Industries and Associates (EFPIA), has resigned his post.

Described by the EFPIA's president Joe Jimenez as “the voice of the pharmaceutical industry in Europe for the past five years”, Bergström was appointed as director general in 2011, succeeding Brian Ager.

Bergström brought almost 20 years of pharmaceutical industry experience to the role, having started out as a pharmacist before holding a number of senior positions in regulatory affairs for Novartis and Roche.

He had been a member of the EFPIA board for a number of years prior to taking on the top job, joining the association from Swedish research-based pharmaceutical association LIF where he served as its director general.

Commenting on his decision to resign, Bergström said: “I am proud to leave EFPIA at a time when we have developed policies that promote innovation and patient access, such as through the focus on outcomes and on adaptive pathways to speed up the development of new medicines.

“After 15 fantastic years leading industry associations in Sweden and in Brussels, it is time for me to take on a fresh challenge.”

Led by Bergström, the search for his replacement is underway, and he has committed to continuing on as director general until a successor has been identified.

2nd September 2016

From: Healthcare

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Evoke Kyne

Evoke Kyne is an award-winning communications agency that harnesses insight, experience and creativity to advance health and wellbeing around the world. We were founded on the belief that...

Latest intelligence

Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....
Top-10 Reasons Why You Should be Adding Asynchronous Virtual Touchpoints Between Your Real-time Meetings
...